Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

Por Camilla Bjørnbak Holst, Camilla Bjørnbak Holst, Camilla Bjørnbak Holst, Camilla Bjørnbak Holst, Ib Jarle Christensen, Jane Skjøth-Rasmussen, Petra Hamerlik, Hans Skovgaard Poulsen, Julia Sidenius Johansen, Julia Sidenius Johansen, Julia Sidenius Johansen
Publicado em 2020-04-01

miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan.

Por Jakob V Schou, Simona Rossi, Benny V Jensen, Dorte L Nielsen, Per Pfeiffer, Estrid Høgdall, Mette Yilmaz, Sabine Tejpar, Mauro Delorenzi, Mogens Kruhøffer, Julia S Johansen
Publicado em 2014-01-01

Type XX Collagen Is Elevated in Circulation of Patients with Solid Tumors

Por Jeppe Thorlacius-Ussing, Christina Jensen, Emilie A. Madsen, Neel I. Nissen, Tina Manon-Jensen, Inna M. Chen, Julia S. Johansen, Hadi M. H. Diab, Lars N. Jørgensen, Morten A. Karsdal, Nicholas Willumsen
Publicado em 2022-04-01

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab.

Por Mogens K Boisen, Christian Dehlendorff, Dorte Linnemann, Boye S Nielsen, Jim S Larsen, Kell Osterlind, Svend E Nielsen, Line S Tarpgaard, Camilla Qvortrup, Per Pfeiffer, Niels H Holländer, Nina Keldsen, Torben F Hansen, Brita B Jensen, Estrid V S Høgdall, Benny V Jensen, Julia S Johansen
Publicado em 2014-01-01